[Policy Recommendations] “Setting Appropriate Outcome Indices in the Next AMR Action Plan” (AMR Alliance Japan, October 18, 2021)
date : 10/18/2021
Tags: AMR
AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) has released a policy recommendations, “Setting Appropriate Outcome Indices in the Next AMR Action Plan.”
The Japanese government enacted the “National Action Plan on Antimicrobial Resistance 2016-2020 (NAP 2016-2020)” in April 2016. With the period of that plan now ended, AMR Alliance Japan convened a meeting of experts to discuss the outcome indices of the previous plan and how they might be revised for a future National Action Plan on Antimicrobial Resistance (the “next NAP”). This discussion led to the recommendations described below.
AMR Alliance Japan’s recommendations consist of three sections. First, the recommendations provide an overview of the outcome indices and corresponding numerical targets used for the NAP 2016 – 2020. Second, the recommendations present an intellectual framework for setting outcome indices and numerical targets in the next NAP. Third, based on the aforementioned framework, specific outcome indices are suggested for the human, animals, food, and environmental sectors.
AMR Alliance Japan hopes that these recommendation will serve as a reference for the creation of a new NAP in Japan in the future.
To view the full content of the recommendations, please refer to the PDF below.
Top Research & Recommendations Posts
- [Policy Recommendations] Improving Patient Access to Genomic Cancer Medicine (August 10, 2023)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Event Report and Discussion Points] AI Diagnostic Support Project Expert Meeting: “The Roles of Industry, Government, Academia, and Civil Society in the Era of AI-Assisted Diagnosis” (May 25, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
Featured Posts
-
2026-05-13
[Registration Open] HGPI Salon 2025-2026 Looking Ahead to the Future of Japan’s Social Security System “Session 5: The Value of Healthcare in Society – Perspectives from the Reiwa Era” (June 29, 2026)
-
2026-06-04
[Registration Open] (Webinar) The 3rd J-PEP Seminar “Social Participation of People with Intractable Diseases and the Potential of a New Way of Working — ‘RD Workers’ — Lessons from Policy Advocacy Practice” (July 22, 2026)
-
2026-06-15
[Registration Open] (Hybrid Format) Multidisciplinary Symposium for Cardiology, Nephrology, and Metabolic Medicine “Future Actions for Making Full Use of the Health Checkup System: Connecting Checkups to Treatment From the Perspective of Data Linkage” (July 6, 2026)



